ES2060740T3 - Vacunas de virus vivos para la enfermedad de newcastle. - Google Patents
Vacunas de virus vivos para la enfermedad de newcastle.Info
- Publication number
- ES2060740T3 ES2060740T3 ES89201837T ES89201837T ES2060740T3 ES 2060740 T3 ES2060740 T3 ES 2060740T3 ES 89201837 T ES89201837 T ES 89201837T ES 89201837 T ES89201837 T ES 89201837T ES 2060740 T3 ES2060740 T3 ES 2060740T3
- Authority
- ES
- Spain
- Prior art keywords
- newcastle disease
- live virus
- virus vaccines
- cncm
- log
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/17—Newcastle disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/544—Mucosal route to the airways
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/948—Microorganisms using viruses or cell lines
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Pulmonology (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
LA INVENCION SE REFIERE A UNA VACUNA DE VIRUS VIVO CONTRA LA ENFERMEDAD DE NEWCASTLE, QUE CONTIENE POR LO MENOS 10 LOG 5,5 EID50 POR DOSIS DE LA CEPA NDW, DEPOSITADA EN EL CNCM DEL INSTITUTO PASTEUR DE PARIS CON EL N I-781.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL8801819 | 1988-07-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2060740T3 true ES2060740T3 (es) | 1994-12-01 |
Family
ID=19852645
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES89201837T Expired - Lifetime ES2060740T3 (es) | 1988-07-18 | 1989-07-12 | Vacunas de virus vivos para la enfermedad de newcastle. |
Country Status (9)
Country | Link |
---|---|
US (1) | US5149530A (es) |
EP (1) | EP0351908B1 (es) |
JP (1) | JP2655726B2 (es) |
AT (1) | ATE112490T1 (es) |
DE (1) | DE68918649T2 (es) |
DK (1) | DK175318B1 (es) |
ES (1) | ES2060740T3 (es) |
HU (1) | HU204439B (es) |
IE (1) | IE65736B1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5250298A (en) * | 1988-10-07 | 1993-10-05 | University Of Delaware | Live attenuated newcastle disease virus vaccines and preparation thereof |
FR2682966B1 (fr) * | 1991-10-29 | 1994-12-02 | Rhone Merieux | Preparation d'antigenes et de vaccins du virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie. |
CA2181862C (en) * | 1995-08-01 | 2009-12-22 | Carla Christina Schrier | Mild newcastle disease virus vaccine |
EP0770397B1 (en) * | 1995-10-18 | 2004-04-21 | Akzo Nobel N.V. | Newcastle disease virus combination vaccine |
EP0848956A1 (en) * | 1996-12-17 | 1998-06-24 | Dimminaco Ag/Sa/Ltd. | In ovo vaccination against Newcastle Disease |
TW200502402A (en) * | 2002-12-06 | 2005-01-16 | Wyeth Corp | Escape mutants of newcastle disease virus as marker vaccines |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2798835A (en) * | 1954-01-18 | 1957-07-09 | American Cyanamid Co | Newcastle disease and infectious bronchitis vaccines and production thereof |
US3876763A (en) * | 1970-12-29 | 1975-04-08 | Shionogi & Co | Infectious coryza infectious bronchitis and newcastle disease vaccines and production thereof |
US4053583A (en) * | 1976-03-01 | 1977-10-11 | Smithkline Corporation | Live newcastle disease virus vaccines |
BE853923A (fr) * | 1977-04-25 | 1977-10-25 | Rit Rech Ind Therapeut | Nouveau vaccin vivant ameliore contre le pseudopeste aviaire et son procede de preparation |
DE2966914D1 (en) * | 1978-09-14 | 1984-05-24 | Gist Brocades Nv | Combined vaccine active against newcastle disease and egg production drop caused by adeno-like viruses, process for preparing it, adeno-like and newcastle disease virus strains |
SU826584A1 (ru) * | 1979-10-29 | 1982-11-07 | Всесоюзный государственный научно-контрольный институт ветеринарных препаратов | Вакцина против ньюкаслской болезни птиц,способ ее изготовлени и способ профилактики ньюкаслской болезни птиц |
-
1989
- 1989-07-12 AT AT89201837T patent/ATE112490T1/de not_active IP Right Cessation
- 1989-07-12 ES ES89201837T patent/ES2060740T3/es not_active Expired - Lifetime
- 1989-07-12 DE DE68918649T patent/DE68918649T2/de not_active Expired - Lifetime
- 1989-07-12 EP EP89201837A patent/EP0351908B1/en not_active Expired - Lifetime
- 1989-07-13 DK DK198903471A patent/DK175318B1/da not_active IP Right Cessation
- 1989-07-13 US US07/379,232 patent/US5149530A/en not_active Expired - Lifetime
- 1989-07-14 HU HU893582A patent/HU204439B/hu unknown
- 1989-07-14 IE IE228489A patent/IE65736B1/en not_active IP Right Cessation
- 1989-07-17 JP JP1182740A patent/JP2655726B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH0269422A (ja) | 1990-03-08 |
IE892284L (en) | 1990-01-18 |
DK175318B1 (da) | 2004-08-16 |
HU204439B (en) | 1992-01-28 |
EP0351908B1 (en) | 1994-10-05 |
ATE112490T1 (de) | 1994-10-15 |
DE68918649T2 (de) | 1995-03-23 |
IE65736B1 (en) | 1995-11-15 |
DK347189A (da) | 1990-01-19 |
HUT52703A (en) | 1990-08-28 |
EP0351908A1 (en) | 1990-01-24 |
JP2655726B2 (ja) | 1997-09-24 |
DE68918649D1 (de) | 1994-11-10 |
DK347189D0 (da) | 1989-07-13 |
US5149530A (en) | 1992-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO871313L (no) | Fremgangsmaate for fremstilling av virusvaksine. | |
ES2095355T3 (es) | Material transparente para usos dentales. | |
KR970009347B1 (en) | Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3 | |
IL78913A (en) | Synthetic vaccines for foot and mouth disease,their preparation and use | |
GB2202327B (en) | Influenza vaccine | |
HUT46858A (en) | Process for producing vaccine against coronavirus of dogs | |
ES2060740T3 (es) | Vacunas de virus vivos para la enfermedad de newcastle. | |
ATE102650T1 (de) | Mutanten des infektioesen bovinen rhinotracheitisvirus, vakzine die sie enthalten, verfahren zu ihrer herstellung und ihrer verwendung. | |
PT833903E (pt) | Vacina multivalente de coroanavirus de bovino e metodo para tratar a infeccao decoronavirus de bovino | |
CA2273074A1 (en) | In ovo vaccination against newcastle disease | |
CA2015828A1 (en) | Canine corona virus vaccine | |
DE3681229D1 (de) | Impfstoffe fuer einen tag alte huehner gegen die infektioese bronchitis. | |
FR2580176B1 (fr) | Vaccin antirabique avirulent | |
ES482549A0 (es) | Un metodo para la preparacion de una composicion de virus herpes | |
ES2058570T3 (es) | Procedimiento para la obtencion de una vacuna antirrabica no virulenta. | |
DE3279264D1 (en) | Method of immunizing pigs against aujeszky's disease | |
ATE84722T1 (de) | Tollwut-lebendimpfstoff. | |
Wawrzkiewicz et al. | Biological properties of distemper attenuated strain propagated in chick fibroblasts in the medium of own production. | |
ES471766A1 (es) | Un procedimiento de preparacion de un virus vivo atenuado dela para-influenza | |
Zourbas et al. | Immunization of dental surgeons against hepatitis B virus infection. | |
RU96108623A (ru) | Штамм coronavirus canine используемый для контроля иммуногенной активности вакцин и получения сывороток для лечения и диагностики коронавирусной инфекции собак | |
UA23884A (uk) | Спосіб підвищення імунітету у сільськогосподарськи х птиць при вакцинації її живими вірус-вакцинами |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 351908 Country of ref document: ES |